Exscientia Plc American Depositary Shares
EXAI
EXAI was delisted on the 19th of November, 2024.
34 hedge funds and large institutions have $734M invested in Exscientia Plc American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$275M |
| 2 |
SGA
SB Global Advisers
London,
United Kingdom
|
+$119M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$85M |
| 4 |
LCM
Laurion Capital Management
New York
|
+$44.8M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$34.6M |
Top Sellers
EXAI Hedge Fund Activity: Q4 2021 in Review
34 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Exscientia Plc American Depositary Shares (EXAI) for Q4 2021, worth a combined $734M.
Buyers outnumbered sellers: 34 funds opened new EXAI positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $275M.
- 34 institutional investors held Exscientia Plc American Depositary Shares (EXAI) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $734M of Exscientia Plc American Depositary Shares stock for Q4 2021.
- 34 funds opened new Exscientia Plc American Depositary Shares positions in Q4 2021 and 0 closed out, a net change of +34 holders.
- The largest Exscientia Plc American Depositary Shares buyer in Q4 2021 was Novo Holdings A/S, an estimated $275M added.
Based on aggregated 13F filings for Q4 2021.